CP-185 An innovative treatment adherence tool

• Published in: European journal of hospital pharmacy. Science and practice 2017-03, Vol.24 (Suppl 1), p.A83-A83
• Main Authors: Anastasi, A, Grech, L, Inglott, A Serracino, Azzopardi, LM
• Format: Article
• Language: English
• Subjects: Heart failure; Patient compliance; Questionnaires
• ISSN: 2047-9956; 2047-9964
• DOI: 10.1136/ejhpharm-2017-000640.183

BackgroundNon-adherence in heart failure leads to hospital admissions and fatalities. The Morisky scale may be adequate in some clinical scenarios, yet the score is selected by balancing sensitivity and positive predictive values.1 PurposeTo measure treatment adherence using a novel model that achieves a good outcome in pharmaceutical care.Material and methodsThe questionnaire was developed and validated in Maltese ‘Kwestjonarju ghall-Uzu tal-Medicina u l-pazjent’ (KUMP) and forward translated into English ‘Treatment adherence questionnaire’ (TAQ). The tool is a 13 item questionnaire with the last question embedding 7 sub-questions on various non-adherence scenarios. The questions tackle knowledge, patient self-care, access, communication and appropriate medicine use with six possible answer categories from ‘never’ to ‘always’. Scoring for parts A and B is different, to facilitate understanding of all of the questions by the individual respondent with a maximum score of 100. A higher score indicates higher adherence.ResultsThe questionnaire’s good content coverage and acceptable item properties resulted in positive expert review ratings with a high reliability score (Κ=0.89; p